Sign in
Taking people in United StatesNo phase

Collecting body samples from people with retinal eye diseases and healthy volunteers

Collects hair, skin, saliva, urine or blood from people with retinal diseases and healthy volunteers.

Key facts

Who runs it
National Eye Institute (NEI)
Where
Bethesda, United StatesSee the site
Trial code
Registry title
Cell Collection to Study Eye Diseases
Status
Recruiting
People taking part
930 people, planned
Started
7 Sept 2011
Type of study
Observational, 2 groups
Record updated
10 November 2026

Who can take part

The trial is looking for people with an eye disease, such as a degenerative retinal disease, and for healthy volunteers of similar age, sex and ethnicity. Everyone gives hair, saliva, urine, blood and/or skin samples.

Age
People with an eye condition: 1 year or older. People with Best disease, L-ORD or AMD: 18 years or older. People without eye disease: 7 years or older.
Sex
All sexes can join.
Disease stage
An eye condition such as degenerative retinal disease, optic atrophy, microphthalmia/anophthalmia, ciliopathy, or another eye developmental or degenerative condition. Healthy volunteers must be free of eye disease.
Biomarker or test result
Healthy volunteers paired with someone with AMD must not have drusen greater than 63 microns in size.
Main reasons for not taking part
  • Cannot follow the study procedures
  • A systemic disease that makes it hard to give samples, such as a bleeding disorder or a genetic risk of infections
  • Cannot give a skin biopsy, urine sample or blood sample (young children may be left out)
  • For clinical-grade cell lines: low blood counts, fever, or active cancer or cancer in the past five years
  • For clinical-grade cell lines: past exposure to HIV or hepatitis B or C, or a positive blood-borne infection test
Show the full registry criteria (18)Hide the full registry criteria

Who can take part

  • Participant must be greater than 18 years of age, as of the date of enrollment. There is no upper age limit for donor enrollment
  • Participant is able to provide a punch skin biopsy and 200 ml of peripheral venous blood
  • Participant is willing and eligible to co-enroll in NEI protocol 15-EI-0128

Who cannot take part

  • Participant has a systemic disease that, in the opinion of the investigator, compromises the ability to provide adequate samples. Examples of co-existing diseases that would exclude a participant include a bleeding diathesis or a genetic susceptibility to infections, particularly cutaneous infections; ADDITIONAL CRITERIA FOR CLNICAL-GRADE CELL LINE GENERATION:; The additional eligibility criteria must be met for participants donating samples for the generation of clinical-grade cell lines
  • Participant has medical history that includes any of the following:; Thrombocytopenia or other blood dyscrasias; Bleeding diathesis; Antibiotic use within the prior 48 hours; Active cancer or history of cancer within the past five years; History of exposure to transfusion transmitted diseases including HIV and hepatitis B and C as defined by the Standards for Blood; Banking and Transfusion Services, American Association of Blood Banks; Travel to an area where malaria is endemic as defined by the CDC (www.cdc.gov/travel); At risk for the possible transmission of Creuzefeldt-Jackob Disease (CJD) and Variant Creuzefeldt-Jackob Disease (vCJD) as described in the FDA Guidance for Industry, January 9, 2002, "Revised Preventive Measures to Reduce the Possible Risk of Transfusion of Creuzefeldt-Jackob Disease (CJD) and Variant Creuzefeldt-Jackob Disease (vCJD) by Blood and Blood Products"
  • Participant has positive tests for blood borne pathogens (as required by the Standards for Blood Banks and Transfusion Services, American Association of Blood Banks. The currently required tests include anti-HIV1/2, anti-HCV, anti-HBc, Anti-HTLV I/II, anti-T. Cruzi, HBsAg, syphilis, and molecular testing for West Nile virus, HCV, HBV, and HIV-1)
  • Participant has Hemoglobin level:; African American women <11.5 grams/dL; Other women < 12.0 grams/dL; Men <12.5 grams/dL
  • Participant has Platelets <150 x 103/microL
  • Participant has Absolute neutrophil count <1.0 x 103/microL
  • A participant is not eligible if any of the following exclusion criteria are present
  • Participant is unable to comply with study procedures
  • Participant is currently febrile (temperature > 38 degrees C)
  • Participant has low hematocrit (HCT):; African American women < 34%; Other women <36%; Men <38%

Other criteria

  • INCLUSION CRITERIA:; To be eligible, participants must meet the following inclusion criteria
  • Have the ability to understand and sign an informed consent or have a parent/legal guardian to do so if they are minor children or have a legally authorized representative if they are adults without consent capacity
  • Participant meets one of the following criteria:; Participant has been diagnosed with an ocular condition of interest including but not limited to: degenerative retinal diseases, optic atrophy, microphthalmia/anophthalmia, ciliopathy, and other ocular developmental or degenerative conditions; Participant is free of eye diseases and could serve as an unaffected control. Participant's age, sex, and ethnicity must match an existing participant with one of the eye diseases under study. Control participants matched to AMD participants must not have drusen greater than 63 microns in size
  • Adult participant is able to provide a punch skin biopsy and 30 mL of peripheral venous blood OR child participant is able to provide a punch skin biopsy and the lesser of 5 mL/kg or 30 mL of peripheral venous blood. Healthy, unaffected children will only have one skin punch biopsy done 3mm or less in size. In affected participants, an additional punch may be gathered if the initial sample does not contain adequate cells. This will be taken from children ages seven years and older. Sampling of ten occipital hairs and/or saliva may be pursued at the investigator's discretion. Participants not able to provide a skin biopsy or blood sample may opt to provide 100-200 ml of fresh urine. As a rule, samples will be collected on non-sedated/anesthetized participants. Sedation/anesthesia will NOT be used solely for the purpose of sample collection. In rare instances where a minor requires sedation for another medically indicated procedure, samples may be collected at the time of sedation/anesthesia. Because young children may not be able to cooperate with sample collection, those unable to provide a skin biopsy, urine sample or a blood sample may be excluded from the study, based on the judgment of the examining investigator
  • Participant meets one of the following criteria:; Participant affected with an ocular condition is one year of age or older; Participant affected with Best disease, L-ORD, or AMD is 18 years of age or older; Unaffected participant is seven years of age or older and willing and able to provide assent

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

This trial is currently available in United States.

  • National Institutes of Health Clinical CenterBethesda, United StatesContact: Nancy Chen, B.S.Taking people

About the trial

What the trial wants to find out

Background:

Read full original descriptionShow less

- Best Vitelliform Dystrophy (Best disease), Late-Onset Retinal Degeneration (L-ORD), and Age-Related Macular Degeneration (AMD) all affect the retina, the light sensing area at the back of the eye. Doctors cannot safely obtain retinal cells to study these diseases. However, cells collected from hair follicles, skin, saliva, urine, and blood can be used for research. Researchers want to collect cells from people with Best disease, L-ORD, and AMD, and compare their cells with those of healthy volunteers.

Objectives:

- To collect hair, skin, saliva, urine, and/or blood samples to study three eye diseases that affect the retina: Best disease, L-ORD, and AMD.

Eligibility:

* Individuals affected with ocular condition is one year of age or older. * Individuals affected with Best disease, L-ORD, or AMD is 18 years of age or older. * Unaffected individuals are seven years of age or older.

Design:

* The study requires one visit to the National Eye Institute. * Participants will be screened with a medical and eye disease history. They may also have an eye exam. * Participants will provide a hair sample, saliva sample, urine sample, blood sample, and/or a skin biopsy. The hair will be collected from the back of the head, and the skin will be collected from the inside of the upper arm.

The 2 groups in the trial

  • Affected

    Participants affected by ocular diseases/conditions.

  • Healthy Volunteers

    Age, sex, and ethnicity-matched to participants with ocular conditions or the unaffected relatives of participants with ocular conditions

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls
Plain-language title
Collecting body samples from people with retinal eye diseases and healthy volunteersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Criteria questions
Built from NCT01432847, who can take part
Record updated
10 November 2026